In the present study, pituitary isografted animals serve as a model for evaluating the changes in differentiation, cell proliferation and programmed cell death (apoptosis) in mammary epithelial cells during carcinogenesis. The percentage of bromodeoxyuridine (BrdU)-labeled ductal and alveolar cells was significantly higher in pituitary isografted animals than in non-isografted control animals. BrdUlabeled cells increased in lobular hyperplastic nodules, keratinized nodules and mammary carcinomas; similar changes were observed with apoptotic cells, which were rare in mammary glands of adult non-isografted animals (one to three apoptotic cells per 2000 mammary epithelial cells), but their number increased in hyperplastic lesions and mammary carcinomas. Among hyperplastic nodular lesions, variants with high, moderate and low proliferative activity and/or apoptotic cell death were identified, which suggests that they may have different growth potentials and different propensities for malignant transformation. After removing pituitary isografts, apoptosis occurs in hyperplastic lesions but not in mammary carcinomasimplying that malignant tumors are hormone-independent. The dynamics of the changes in apoptotic cell death among various hyperplastic lesions after removal of pituitary isografts suggests that these lesions are composed of heterogeneous cell populations, as far as the initiation of apoptosis is concerned. Our data indicate that apoptosis can be used together with cell proliferation as a potential marker in characterizing the growth potential and phenotypic diversity of hyperplastic, premalignant and malignant mammary gland lesions.
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changes at the cellular and molecular levels (1-3). These changes result in selection of stem cell type populations of pre-neoplastic and neoplastic cells that have proliferative advantages over the surrounding non-transformed cells. Together with cell proliferation, programmed cell death (apoptosis) also plays a substantial role in the regulation of normal and neoplastic cell growth and may even affect the phenotype of tumors (4) (5) (6) . In hormone-dependent cell systems, withdrawing the stimulatory hormone(s) led to a decrease in proliferative activity and an increase in apoptosis (7, 8) . However, very few data are available on the role of apoptosis in mammary carcinogenesis (9) .
Earlier studies have shown that pituitary-isografted (PI) animals have increased circulatory levels of prolactin, which stimulates the MEC to proliferate and to develop hyperplastic lesions and malignant tumors within a year (10) (11) (12) . Recently, we published data indicating that proliferative activity and lobulo-alveolar differentiation of mammary epithelial cells can modulate the carcinogenic effect of /V-methyl-A'-nitrosourea (MNU) in PI mice (13, 14) . In the present study, we extended our experiments on PI animals and observed that the development of mammary carcinomas is preceded by well-defined stages of diffuse (1-4 months) and nodular type (5-11 months) hyperplasia. We also found that most hyperplastic and dysplastic mammary gland lesions in PI animals are hormone (prolactin)-dependent and regress after removal of pituitary isografts, which suggests that apoptosis is involved in this process. Studies on weaning and ovariectomized mice have shown that apoptosis occurs in mammary gland within the first several days and is the main cause of disintegration of lobulo-alveolar structures (15) (16) (17) . To the best of our knowledge, this is the first report devoted to the changes in apoptosis during mammary carcinogenesis in PI animals.
We hypothesize that the neoplastic transformation of MEC in PI animals is a multi-step process associated with deregulation of the relationship between cell proliferation and cell death. We further assume that this deregulation may occur in the early hyperplastic and premalignant stages of mammary carcinogenesis. Here, data are presented supporting this hypothesis.
Introduction
Over the past several years, data have been published indicating that neoplastic transformation of mammary epithelial cells (MEC*) in rodents is a multi-step process involving various 
Materials and methods

Animals
BALB/c virgin female mice were obtained from the Cancer Research Laboratory, University of California at Berkeley. They were housed, five-to-a-cage, in a temperature-controlled room with a fixed light cycle. Food pellets (Wayne Lab Blox F-G; Allied Mills, Inc., Chicago, IL) and water were available ad libitum.
Pituitary isografts (PI)
Twelve-week-old mice received two anterior pituitary isografts under the right kidney capsule as a means of increasing circulating prolactin levels to provide stimulation of mammary gland cell proliferation (11, 12) . The glands remained in place for the duration of the experiment. Sham-operated animals served as controls.
Removal of pituitary isografts
The animals were anesthetized with Nembutal. A small skin incision over the right kidney region was made, which was further extended by a small opening of the abdominal wall. The isografts attached to the kidney capsule were easily identified and cauterized by electrocauter. The viability of the isografts was assessed under the dissection microscope by their red color and the infiltrating blood vessels. Serving as a second marker of viability of PI was mammary gland morphology, which was composed entirely of lobulo-alveolar structures. Animals with nonfunctional PI were eliminated from the study. The efficacy of electrocoagulation was verified at autopsy. Pis were removed 9-14 months after their implantation.
Bromodeoxyuridinc (Brdil) administration
BrdU (Sigma Chemical Co., St Louis, MO) was dissolved in PBS at 20 mg/ ml and injected i.p. (50 mg/kg body wt) 2 h before sacrifice. For 3-and 7-day labeling with BrdU, osmotic pumps (Models 1003 and 1007; Alza Co., Palo Alto, CA) were implanted s.c. over the dorsal thoraco-lumbar area (13) .
Whole mounts of mammary glands
Abdominal mammary glands were examined after being separated from the surrounding soft tissues. If tumor nodules were found, they were excised. One part was used for histology and immunocytochemistry, and the other part was used for DNA flow cytometry (FCM) (data not shown). The wholemounts of the mammary glands were further processed and stained with hematoxylin, as described previously by Medina (18) . For histomorphology, tissue samples were embedded in paraffin, sliced into 4-um sections, and stained with hematoxylin and eosin (H&E).
Identification of BrdU-labeled cells
After deparaffinization, the tissue sections were treated wtih 2 N HC1 at 40°C for 1 h, immersed for 15 min in a 3% solution of H2O2 in methanol for inhibition of endogenous peroxidase and blocked with 5% normal rabbit serum for 30 min. The BrdU-labeled cells cells were identified by a rat antiBrdU monoclonal antibody (B6E-250, IgG2; Sera Lab., UK), a peroxidase conjugated rabbit IgG to rat immunoglobulin (Dako), and a staining solution of DBA (1 mg/ml) and 0.01% H 2 O 2 in PBS, as described earlier (13) .
Identification of apoptotic cells
The apoptotic cells were evaluated using the TUNEL method (19) and H&E stained sections. A cut-off level was established for counting brown staining apoptotic cells. The values for apoptotic index (AI) obtained by the TUNEL method and those obtained from H&E stained sections indicated a high correlation coefficient (r 2 = 0.782).
Serum hormone concentrations
Trunk blood was obtained and serum was harvested from the animals at the time of death. All blood samples were collected on the afternoon of proestrus within a 2 h interval. The circulating concentrations of prolactin, progesterone and 17[}-estradiol were measured by radioimmunoassay (12, 20) . Progesterone and 17fJ-estradiol immunoassays were modified to measure mouse serum by constructing the standard curves from reference standards prepared in charcoalstripped mouse serum. ANOVA was used for statistical analysis.
Statistics
Differences between various groups and parameters were estimated using Fisher's (-test.
Results
Hyperplastic and premalignant mammary gland lesions
In previous studies, we showed that during the first 2 months after isografting the animal's mammary gland is composed predominantly of lobulo-alveolar structures (13, 14) . In animals bearing PI for 4-5 months, the lobulo-alveolar differentiation of MEC progressed, and the mammary gland was almost entirely occupied by lobular structures. A further prolongation of pituitary stimulation led to the development of a variety of hyperplastic ductal and alveolar lesions of nodular type (Table  I) . Based on their histomorphology, these lesions were classified into several groups: (i) hyperplastic alveolar nodules (HAN), which resembled the alveolar structures of a lactating mammary gland ( Figure 1A) ; (ii) lobular hyperplastic nodules (LHN), which were composed of closely situated acini and intralobular ducts, both separated by a small amount of stroma ( Figure IB PRL, prolactin; PR, progesterone, E2, estradiol; PRL, P < 0.01 for all PI groups as compared with the controls; only significant P value differences are given for PR and E2. *P < 0.01; **P < 0.001. right), which were composed predominantly of branching and terminal ducts; and (iv) keratinized nodules (KN), which consisted of keratinized and non-keratinized follicles with differing degrees of differentiation and lymphocytic infiltration ( Figure 1C ). Mammary carcinomas first occurred at 11 months in PI animals, most of which were of the papillary and alveolar type ( Figure ID) .
Serum concentration of prolactin, progesterone and 17f3-estradiol
The data for changes in circulatory levels of protein, progesterone and estradiol during mammary carcinogenesis in PI'animals are presented in Table II . A consistent increase in the prolactin level was found at all time intervals after isografting the animals. At some time points, statistically significant fluctuations in the values of progesterone and estradiol were also observed. Thus, compared to non-isografted animals, progesterone decreased in the group of 22-to 31-week-old animals, whereas estradiol decreased in the eight-week-old group and increased in the 16-to 18-week-old group.
Cell proliferation
In the control, non-isografted BALB/c mice, very few BrdUlabeled cells (<1%) were identified. In all PI animals, a significant increase was found in the percentage of BrdUlabeled cells (Table HI) . However, after 5-8 and 9-14 months, lobules and ductal regions with a high number of BrdU-labeled cells in addition to lobules almost lacking proliferative activity were also identified ( Figure IB) . BrdU in LHN was higher than those in HAN {P < 0.001) and DHN (P < 0.01). Among DHN, usually having low proliferative activity, single acini with a high number of BrdU-labeled cells were also observed ( Figure IB) . In most KN, a high number of BrdU-labeled cells was found ( Figure 1C) . The values of BrdU-labeled tumor cells in papillary and squamous carcinomas were almost similar (P > 0.05). Eight animals pituitary isografted for 9-14 months were infused with BrdU for 3 (four animals) and 7 (four animals) days using osmotic pumps. With this approach, areas of increased proliferative activity with growth fraction close K.T.Christov el al. (Table m) . AI was higher in LHN than in HAN (P < 0.001) and KN (P < 0.01), and it further increased in mammary carcinomas (P < 0.01). By using the values of BrdU-LI and AI, a ratio between both parameters was calculated (Table HI) . BrdU-LI/ AI ratio for acinar and ductal epithelial cells progressively decreased with the time of pituitary isografting. The BrdU/AI ratio also varied among different hyperplastic lesions and mammary carcinomas. On the basis of the values of BrdU-LI and AI, various hyperplastic lesions and mammary carcinomas could be classified into three groups: (i) a high BrdU-LI and a moderate AI; (ii) a moderate or small BrdU-LI and a moderate or small AI; (iii) a small BrdU-LI and a high AI.
Induction of apoptosis
Animals pituitary isografted for 9-14 months were used in these experiments. Apoptosis was induced in mammary glands by removing Pis by electrocauterization. The efficacy of the electrocauterization was assessed at autopsy by lack of isografts 1744 remnants. The percentage of apoptotic cells was evaluated 3, 5 and 7 days after removal of PI (Table IV) . AI increased within the first 3 days in all hyperplastic mammary gland lesions but not in carcinomas. Over the next 4 days, the AI remained unchanged in alveolar cells and decreased in LHN and KN lesions. The increase in AI after removal of PI was associated with a decrease in the percentage of BrdU-labeled cells. Myoepithelial cells remained well organized 3 and 5 days after removal of PI, but later they also underwent apoptosis and were disintegrated by macrophages.
Discussion
In this study, we obtained data indicating that neoplastic transformation of MECs in PI animals is preceded by the development of hyperplastic and dysplastic lesions of a nodular type (HAN, LHN, DHN and KN) , most of which have quite variable proliferative activity and apoptotic cell death. We also observed that in PI animals the prolactin circulatory level is increased, which stimulates MEC to proliferate and to develop lobulo-alveolar structures, hyperplastic lesions and mammary carcinomas. To assess the potential involvement of other mammagenic hormones in mammary carcinogenesis, we also measured the serum concentrations of progesterone and 17(iestradiol (Table II) . At some time intervals, concentrations were found decreased for progesterone (in 22-to 31-week-old animals), decreased for estradiol (in 8-week-old PI animals) and increased for estradiol (14-to 16-week old PI animals), suggesting that both hormones and other factors may also be involved in malignant transformation of MEC in PI animals (22, 23) . The estrus cycle or other physiological factors may also affect the fluctuations of estradiol and progesterone during mammary carcinogenesis (24, 25) . For many years, HAN have been considered the principal preneoplastic lesions in mouse mammary glands because, when serially transplanted into mammary cleared fat pads, they can develop a malignant phenotype (26, 27) . Among 15 animals, we identified only seven HAN, most probably because these nodules are rare in BALB/c mice but frequent in mice bearing MTV (C3H, GH and SHN strains) (18) .
Cell proliferation and apoptosis in mammary carcinogenesis
Contrary to the well characterized biology of HAN, few data are available on the biology and structural organization of LHN, DHN and KN frequently observed in mammary gland of PI animals. In morphology and cell composition, LHN and DHN resembled the lobular hyperplasia (focal nodules) described earlier by Medina (18, 21) . The high BrdU-LI in LHN, the heterogeneity in distribution of proliferating cells, the involvement of terminal ductal epithelial cells in the proliferative process and the occurrence of dysplastic areas suggest that some LHN may undergo malignant transformation. The high number of apoptotic cells and small number of proliferating cells in some DHN suggest a high probability of regression and disintegration. Little is known of the growth potential and hormonal regulation of KN. After removal of PI, most KN regress within 3 months, but some may develop lobulo-alveolar outgrowths when serially transplanted in mammary cleared fat pads (18) . The high percentage of proliferating cells and small number of apoptotic cells in KN and their morphological similarity to squamous carcinomas suggest that some squamous carcinomas may arise from KN. KN were always infiltrated by lymphocytes and mononuclear cells, which indicates that non-apoptotic cell death, most probably mediated by the immune system, is involved in the disintegration of KN.
Apoptosis in mammary glands has been predominantly studied in weaning mice within the first 7 days following removal of the babies (15, 16) . The increased percentage of apoptotic cells in weaning animals has been associated with activation and expression of certain genes, mostly involved in cell cycle control, milk production and intercellular matrix composition (28) . In this study, we observed higher values of BrdU-LI and AI in mammary carcinomas than in hyperplastic ductal and alveolar lesions. This suggests that malignant transformation of MEC in PI animals is associated with an increase in both cell proliferation and apoptosis. Similar data were published recently about cervical neoplasia in which a parallel increase in cell proliferation and apoptosis was also observed, independent of the expression of human papilloma virus (29) . In a recent study on cell proliferation, apoptosis and aneuploidy in breast carcinomas we also observed that in high-grade carcinomas composed of aneuploid cell populations the high number of proliferating cells was accompanied by high apoptotic cell death (30) .
The differences in the values of proliferating and apoptotic cells in various hyperplastic lesions suggest differences in their growth potential and possibly in probability for malignant transformation or regression. In some hyperplastic lesions and mammary carcinomas, cell proliferation and apoptosis seem to follow independent pathways which in normal tissues are strongly regulated in order to keep the cell system in a steady state. However, the growth and progression of various mammary gland lesions is complex and depends not only on the percentage of BrdU-LI and AI but also on the cell cycle time and cell loss (7, 8) .
After removal of PI, we found increased AI and decreased BrdU-LI in hyperplastic lesions but not in mammary carcinomas, which suggests that malignant tumors are hormoneindependent in PI animals. The time-dependent changes in AI among LHN, KN and DHN after removal of PI further suggest that they are composed of heterogeneous cell populations as far as their responsiveness to apoptotic stimuli is concerned: some cells entered apoptosis within the first 1-3 days, whereas others required more time (3-5 days) to do the same. These time-related differences in entering apoptosis might be used as an independent parameter in characterizing the hormone dependence of cell populations in various mammary gland lesions.
In conclusion, by using cell kinetics approaches and markers for proliferating and apoptotic cells, we observed that malignant transformation of mammary epithelial cells is associated with increased cell proliferation and apoptosis. Among hyperplastic mammary gland lesions, variants were identified which had high, moderate and low proliferative activity and/or apoptotic cell death, which suggests different growth potential and likelihood of malignant transformation or regression. After removal of PI, apoptotic cell death was induced in hyperplastic lesions but not in mammary carcinomas. We further observed that, among various hyperplastic nodular lesions, certain cell subpopulations initiate apoptosis at different time intervals after removal of PI, indicating their different sensitivity/ resistance to apoptotic stimuli.
